Privia Health Group, Inc.(PRVA)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Privia Health Group, Inc. (PRVA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PRVA at 60.1/100 on a 32-signal composite quality model, placing it at rank #888 of 2,961 stocks — the top half of the AI-ranked universe. PRVA scores in the top quartile across earnings quality (94.4), revenue growth (78.5). Areas of concern include profitability (39.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 30.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Privia Health Group, Inc. reports quarterly revenue of $632.6M, net income of $9.0M, an operating margin of 1.9%. Top institutional holders of PRVA by reported 13-F value include BlackRock, FMR, Durable Capital Partners, based on the most recent SEC filings. PRVA trades on the Nasdaq exchange and files with the SEC under CIK 1759655. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PRVA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Privia Health Group, Inc. directly from SEC EDGAR.